1.Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Adrenal Glands: Analysis of 21 Patients.
Rajesh PURI ; Ragesh Babu THANDASSERY ; Narendra S CHOUDHARY ; Hardik KOTECHA ; Smruti Ranjan MISRA ; Suraj BHAGAT ; Manish PALIWAL ; Kaushal MADAN ; Neeraj SARAF ; Haimanti SARIN ; Mridula GULERIA ; Randhir SUD
Clinical Endoscopy 2015;48(2):165-170
BACKGROUND/AIMS: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) cytology of adrenal masses helps in etiological diagnosis. The aim of this study was to evaluate the diagnostic yield of EUS-FNA of adrenal masses in cases where other imaging methods failed and/or were not feasible. METHODS: Twenty-one consecutive patients with adrenal masses, in whom adrenal FNA was performed because conventional imaging modalities failed and/or were not feasible, were prospectively evaluated over a period of 3 years. RESULTS: Of the 21 patients (mean age, 56+/-12.2 years; male:female ratio, 2:1), 12 had pyrexia of unknown origin and the other nine underwent evaluation for metastasis. The median lesion size was 2.4x1.6 cm. Ten patients were diagnosed with tuberculosis (shown by the presence of caseating granulomas [n=10] and acid-fast bacilli [n=4]). Two patients had EUS-FNA results suggestive of histoplasmosis. The other patients had metastatic lung carcinoma (n=6), hepatocellular carcinoma (n=1), and adrenal lipoma (n=1) and adrenal myelolipoma (n=1). EUS results were not suggestive of any particular etiology. No procedure-related adverse events occurred. CONCLUSIONS: EUS-FNA is a safe and effective method for evaluating adrenal masses, and it yields diagnosis in cases where tissue diagnosis is impossible or has failed using conventional imaging modalities.
Adrenal Glands*
;
Biopsy, Fine-Needle*
;
Carcinoma, Hepatocellular
;
Diagnosis
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration
;
Endosonography
;
Fever
;
Granuloma
;
Histoplasmosis
;
Humans
;
Lipoma
;
Lung
;
Myelolipoma
;
Neoplasm Metastasis
;
Prospective Studies
;
Tuberculosis
2.Clinical Application of AIMS65 Scores to Predict Outcomes in Patients with Upper Gastrointestinal Hemorrhage.
Ragesh Babu THANDASSERY ; Manik SHARMA ; Anil K JOHN ; Khalid Mohsin AL-EJJI ; Hamidulla WANI ; Khaleel SULTAN ; Muneera AL-MOHANNADI ; Rafie YAKOOB ; Moutaz DERBALA ; Nazeeh AL-DWEIK ; Muhammed Tariq BUTT ; Saad Rashid AL-KAABI
Clinical Endoscopy 2015;48(5):380-384
BACKGROUND/AIMS: To evaluate the ability of the recently proposed albumin, international normalized ratio (INR), mental status, systolic blood pressure, age >65 years (AIMS65) score to predict mortality in patients with acute upper gastrointestinal bleeding (UGIB). METHODS: AIMS65 scores were calculated in 251 consecutive patients presenting with acute UGIB by allotting 1 point each for albumin level <30 g/L, INR >1.5, alteration in mental status, systolic blood pressure < or =90 mm Hg, and age > or =65 years. Risk stratification was done during the initial 12 hours of hospital admission. RESULTS: Intensive care unit (ICU) admission, endoscopic therapy, or surgery were required in 51 patients (20.3%), 64 (25.5%), and 12 (4.8%), respectively. The predictive accuracy of AIMS65 scores > or =2 was high for blood transfusion (area under the receiver operator characteristic curve [AUROC], 0.59), ICU admission (AUROC, 0.61), and mortality (AUROC, 0.74). The overall mortality was 10.3% (n=26), and was 3%, 7.8%, 20%, 36%, and 40% for AIMS65 scores of 0, 1, 2, 3, and 4, respectively; these values were significantly higher in those with scores > or =2 (30.9%) than in those with scores <2 (4.5%, p<0.001). CONCLUSIONS: AIMS65 is a simple, accurate, non-endoscopic risk score that can be applied early (within 12 hours of hospital admission) in patients with acute UGIB. AIMS65 scores > or =2 predict high in-hospital mortality.
Blood Pressure
;
Blood Transfusion
;
Endoscopy
;
Gastrointestinal Hemorrhage*
;
Hemorrhage
;
Hospital Mortality
;
Humans
;
Intensive Care Units
;
International Normalized Ratio
;
Mortality